Advisory Board





  Home >> Management >> Principals



  Raymond L. Rodriguez
  Terry Carlone

Photo: Raymond L. RodriguezRaymond L. Rodriguez, Ph.D., Chairman and Chief Executive Officer

Dr. Rodriguez is one of the early pioneers of biotechnology. Dr. Rodriguez was an A.P. Giannini and NIH Postdoctoral Fellow in the laboratory of Herbert Boyer at the University of California Medical Center in San Francisco, from 1974-77. At UCSF Dr. Rodriguez developed technologies that now serve as the foundation of the modern biotechnology industry. Dr. Rodriguez joined the faculty at the University of California, Davis in 1977. In 1988, Dr. Rodriguez was a Distinguished Visiting Professor in the International Center for Biotechnology at Osaka University, Japan, and in 1991, he was a Visiting Scientist with the Human Genome Project at the Lawrence Livermore National Laboratory. He was also founder and chairman of the International Rice Genome Organization from 1989 to 1992. In 2000, Dr. Rodriguez co-founded the Center for High Performance Computing and Bioinformatics at UC Davis. Dr. Rodriguez currently serves as Director of the NIH-funded Center of Excellence for Nutritional Genomics at UC Davis.

As a professor in the Section of Molecular and Cellular Biology, Dr. Rodriguez is actively involved in research and teaching at the undergraduate and graduate level. Dr. Rodriguez also is a member of numerous scientific organizations and serves on several advisory committees including serving as an advisor to the NIH since 1988. He has published nearly 100 articles and books on genetic engineering and biotechnology and currently holds 16 biotech patents.

In 1991, Dr. Rodriguez formed Davis Bioscience Associates, the predecessor of Davis Bioscience Group. In 1993, he founded Ventria Bioscience Inc., a plant-based life sciences company producing genetically enhanced foods with novel health and medical benefits. He served as chairman of Ventria’s Board until 1999.

Dr. Rodriguez lectures widely on biotechnology, and is regarded internationally as an opinion leader on biotechnology. Dr. Rodriguez received his Ph.D. in Biology from the University of California, Santa Cruz in 1974.

Photo: Terry D. CarloneTerry D. Carlone, J.D., President

Mr. Carlone is an attorney and entrepreneur who has founded or co-founded several venture-backed companies. In addition, he is founder and shareholder of Capital Law Group, a Sacramento-based firm that specializes in representing high tech and biotechnology startup and emerging companies in all stages of corporate growth and development, including entity formation and organization, capital formation and offerings, mergers and acquisitions, corporate partnering, intellectual property protection and strategies, technology transfer and licensing. He acts as General Counsel to, and/or serves on management committees or advisory boards for, several high tech and life sciences companies. He also is a member of the board of directors of Altergy Systems, AngelStaffing, Inc., Bays-Brown Laboratories, Milagen, Inc., and NutraGenomics.

Mr. Carlone has practiced law with the Sacramento office of McDonough, Holland & Allen, where he headed the expansion of McDonough's high tech and biotechnology business; Weintraub Genshlea & Sproul, where he was chairman of the firm's Technology and Intellectual Property Group; and Pillsbury Madison & Sutro (now Pillsbury Winthrop LLP), in both San Francisco and Washington D.C., where he was one of three founding attorneys of the firm's Washington, D.C. office in 1980. He also was both senior in-house legal counsel (1988-1990) and corporate real estate asset manager (1990-1995) for Alexander & Baldwin, Inc., a publicly traded corporation based in Honolulu. Mr. Carlone was a licensed Hawaii Real Estate Broker from 1990 to 1995.

Mr. Carlone received his B.A. from Northwestern University in 1973 and his J.D. from Georgetown University in 1976. He is a member of the State Bar of California, District of Columbia Bar, and Hawaii State Bar Association. He also is actively involved in the community. He is a member of the Sacramento Angels and serves on the board of directors of the Golden Capital Network (Executive Committee, 1999-Present), and has served on the boards of Access Capital (1997-1999), the Sacramento Entrepreneurship Academy (1997-1999), the Sacramento Valley Forum for Growth Companies (1997-1999, Chairman 1999) and the Sacramento Region Chapter of the International Association for Corporate Growth (2000-2001). He frequently lectures or serves as a panelist on investing in technology-based startups, capital formation, intellectual property creation and protection, technology transfer, licensing, strategic alliances, and other issues important to startup and emerging growth companies and the people who invest in them.


  site map  |  contact us

   2007 © Davis Bioscience Group. All rights reserved. Terms of Use.

 Client Login
 Biotech News Links
 Great Reading
 Contact Us